Global Fight against Child Hunger Gains Awareness through No-Fees Campaign by PR Agencies

EurocomFor the second year running a pro-bono cooperation between the United Nations World Food Programme and public relations agencies in Eurocom Worldwide helped promote the global event ‘Walk the World’. Media coverage of the event generated huge interest and hundreds of thousands of participants around the world.

CHEMTURA NAMES CHETLAND AS BUSINESS DIRECTOR, PHOSPHORUS FLAME RETARDANTS

Chemtura Corporation has appointed Janet Chetland as its Business Director, Phosphorus Flame RetardantsMIDDLEBURY, CT – Chemtura Corporation has appointed Janet Chetland as its Business Director, Phosphorus Flame Retardants.

CHEMTURA TO INCREASE CAPACITY FOR EPOXY SOYBEAN OIL

ChemturaMIDDLEBURY, CT - Chemtura Corporation (NYSE:CEM) will increase capacity for epoxy plasticizers by 15% at its Taft, Louisiana manufacturing facility, beginning January 2007.

CHEMTURA NAMES NEW EXEC V.P., PLASTIC ADDITIVES, TO BUILD CUSTOMER PARTNERSHIPS

Chemtura Corporation has named Marcus Meadows-Smith to the position of Executive Vice President for Plastic Additives. The appointment signals a new direction for the world’s largest plastic additives manufacturer.MIDDLEBURY, CT – Chemtura Corporation (NYSE:CEM) has named Marcus Meadows-Smith to the position of Executive Vice President for Plastic Additives. The appointment signals a new direction for the world’s largest plastic additives manufacturer.

GE Plastics zeigt auf der Medica Düsseldorf innovative Materialien und Anwendungsentwicklungen für Hersteller medizintechnischer Geräte

Neuer elektrochirurgischer E-Z Pen™-Kauterstift für den zwölffachen Gebrauch von MEGADYNE Medical Products mit Noryl*Polyphenylenoxid Blends (PPO/PS)- und Ultem*Polyetherimid (PEI)-Kunststoffen von GE>BERGEN OP ZOOM, NIEDERLANDE — 18. September 2006 — Im Mittelpunkt des Messeauftritts von GE Plastics vom 15. bis zum 18. November 2006 auf der Medica in Düsseldorf – Halle 10, Stand A56 – stehen neue Materiallösungen im Bereich der technischen Thermoplaste für erhöhte Hämokompatibilität1 von Blutkontaktanwendungen und Geräten, die eine geringe Proteinbindung erfordern, wie in mehreren diagnostischen und biopharmazeutischen Bereichen. ESTECH setzt für seinen Einweg-Vorhofdepressor ClearView MV™ beispielsweise ein fortschrittliches hämokompatibles Lexan* von GE ein, das bei minimalinvasiven Eingriffen zur Reperatur oder Auswechslung künstlicher Mitralklappen zur hohen Zuverlässigkeit und Biokompatibilität2 des Instruments beiträgt Zu den weiteren von GE auf der Messe präsentierten Kundeninnovationen zählen auch der elektrochirurgische E-Z Pen™ von MEGADYNE und das Narkosemittelzufuhrsystem Aisys® Carestation® von GE Healthcare.

Antioxidants Cooperation to End

SONGWONUlsan, Korea, September 15, 2006 - Songwon Industrial Co., Ltd. and Clariant International Ltd. (Muttenz, Switzerland) announced today that they mutually agreed to end their cooperation in antioxidants after many years of a successful partnership as of January 31, 2008. The decision follows as a result of a strategic re-orientation of both companies based on the global market development.

DSM to invest in new polymer plant in China to produce Akulon® PA6

Royal DSM N.V. today announces that it has decided to invest in a new facility at its Jiangyin site, Jiangsu province, to produce high viscosity grades of Akulon® polyamide 6 (PA6).Royal DSM N.V. today announces that it has decided to invest in a new facility at its Jiangyin site, Jiangsu province, to produce high viscosity grades of Akulon® polyamide 6 (PA6). The new plant is expected to come on stream in Q2 2008. The major proportion of the production is targeted at packaging film production companies in Asia-Pacific. The investment will amount to several tens of millions of USD.

Borouge and Borealis announce world-class Innovation Centre in the UAE

BorougeBorouge and Borealis, leading providers of value creating, innovative plastics solutions, today announced the establishment of a major innovation centre in the UAE. The centre represents a significant investment in Borouge's research capabilities to meet customer needs in the Middle East and Asia Pacific regions.